Iron Oxide as an MRI Contrast Agent for Cell Tracking

Area of Science:

• Biomedical Imaging
• Nanotechnology
• Cell Biology

Background:

• Iron oxide nanoparticles are utilized as contrast agents in magnetic resonance imaging (MRI).
• These agents facilitate the tracking of various cell types for research and clinical applications.
• Combining iron oxide agents with MRI offers advanced capabilities for in vivo and ex vivo cell visualization.

Purpose of the Study:

• To review the properties of iron oxide contrast agents used for cell tracking.
• To provide an overview of cell labeling methods (ex vivo and in vivo) for different cell types.
• To examine applications of iron oxide-enhanced cell tracking in various diseases and vascular conditions.

Main Methods:

• Discussion of coating properties influencing iron oxide nanoparticle performance.
• Overview of labeling techniques for stem cells, red blood cells, and monocytes/macrophages.
• Examination of methods for quantifying iron oxide concentrations and vascular parameters.

Main Results:

• Successful application of iron oxide contrast agents for cell tracking in diverse models.
• Demonstrated utility in tracking cells relevant to stroke, multiple sclerosis, cancer, and vascular malformations.
• Exploration of quantification techniques for iron oxide agents and vascular properties.

Conclusions:

• Iron oxide contrast agents are valuable tools for cell tracking in biomedical research.
• Effective labeling and quantification methods are crucial for successful cell tracking studies.
• This review provides guidance for designing and validating studies using these agents.